Clinical Trial

Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to develop the deep learning-based system that integrates multimodal information to automatically diagnose, stage, and grade thyroid-associated ophthalmopathy (TAO), assist in treatment decision-making, and predict patient prognosis, thereby providing novel tools to support clinical management.
Protocol Amendment History 1 change
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
Trial Details
NCT Number NCT07124572
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions Thyroid Associated Ophthalmopathy
Enrollment 500 participants
Start Date 2022-10-01
Primary Completion 2030-10-01 (estimated)
Study Completion 2031-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-15